Search

Author/Creator Reu, Frederic

1. Microarray-based analysis and clinical validation identify ubiquitin-conjugating enzyme E2E1 (UBE2E1) as a prognostic factor in acute myeloid leukemia. Issue 1 (December 2016)

Authors:
Luo, Hongmei; Qin, Yu; Reu, Frederic; Ye, Sujuan; Dai, Yang; Huang, Jingcao; Wang, Fangfang; Zhang, Dan; Pan, Ling; Zhu, Huanling; Wu, Yu; Niu, Ting; Xiao, Zhijian; Zheng, Yuhuan; Liu, Ting
Journal:
Journal of hematology & oncology
Issue:
Volume 9:Issue 1(2016)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial. Issue 10068 (4th February 2017)

Authors:
Durie, Brian G M; Hoering, Antje; Abidi, Muneer H; Rajkumar, S Vincent; Epstein, Joshua; Kahanic, Stephen P; Thakuri, Mohan; Reu, Frederic; Reynolds, Christopher M; Sexton, Rachael; Orlowski, Robert Z; Barlogie, Bart; Dispenzieri, Angela
Journal:
Lancet
Issue:
Volume 389:Issue 10068(2017)
Page Start:
519
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗